alexa Optical coherence tomography patterns of stent restenosis.
Cardiology

Cardiology

Journal of Cardiovascular Diseases & Diagnosis

Author(s): Gonzalo N, Serruys PW, Okamura T, van Beusekom HM, GarciaGarcia HM,

Abstract Share this page

Abstract BACKGROUND: Stent restenosis is an infrequent but poorly understood clinical problem in the drug-eluting stent era. The aim of the study was to evaluate the morphologic characteristics of stent restenosis by optical coherence tomography (OCT). METHODS: Patients (n = 24, 25 vessels) presenting with angiographically documented stent restenosis were included. Quantitative OCT analysis consisted of lumen and stent area measurement and calculation of restenotic tissue area and burden. Qualitative restenotic tissue analysis included assessment of tissue structure, backscattering and symmetry, visible microvessels, lumen shape, and presence of intraluminal material. RESULTS: By angiography, restenosis was classified as diffuse, focal, and at the margins in 9, 11, and 5 vessels, respectively. By OCT, restenotic tissue structure was layered in 52\%, homogeneous in 28\%, and heterogeneous in 20\%. The predominant backscatter was high in 72\%. Microvessels were visible in 12\%. Lumen shape was irregular in 28\% and there was intraluminal material in 20\%. The mean restenotic tissue symmetry ratio was 0.58 +/- 0.19. Heterogeneous and low scattering restenotic tissue was more frequent in focal (45.5\% and 54.5\%, respectively) than in diffuse (0 and 11.1\%) and margin restenosis (0 and 0\%) (P = .005 for heterogeneous, P = .03 for low scattering). Restenosis patients with unstable angina symptoms presented more frequently irregular lumen shape (60 vs 6.7\%, P = .007). Stents implanted
  • DOI: 10.1016/j.ahj.2009.06.004
  • This article was published in Am Heart J and referenced in Journal of Cardiovascular Diseases & Diagnosis

    Relevant Expert PPTs

    Relevant Speaker PPTs

    • Donald silverberg
      Is correction of iron deficiency a new addition to the treatment of heart failure?
      PPT Version | PDF Version
    • Ahmed Zeidan
      Effects of intravenous iron in chronic kidney disease and heart failure
      PPT Version | PDF Version
    • Yosef Yarden
      Classically, the 3’untranslated region (3’UTR) is that region in eukaryotic protein-coding genes from the translation termination codon to the polyA signal. It is transcribed as an integral part of the mRNA encoded by the gene. However, there exists another kind of RNA, which consists of the 3’UTR alone, without all other elements in mRNA such as 5’UTR and coding region. The importance of independent 3’UTR RNA (referred as I3’UTR) was prompted by results of artificially introducing such RNA species into malignant mammalian cells. Since 1991, we found that the middle part of the 3’UTR of the human nuclear factor for interleukin-6 (NF-IL6) or C/EBP gene exerted tumor suppression effect in vivo. Our subsequent studies showed that transfection of C/EBP 3’UTR led to down-regulation of several genes favorable for malignancy and to up-regulation of some genes favorable for phenotypic reversion. Also, it was shown that the sequences near the termini of the C/EBP 3’UTR were important for its tumor suppression activity. Then, the C/EBP 3’UTR was found to directly inhibit the phosphorylation activity of protein kinase CPKC in SMMC-7721, a hepatocarcinoma cell line. Recently, an AU-rich region in the C/EBP 3’UTR was found also to be responsible for its tumor suppression. Recently we have also found evidence that the independent C/EBP 3’UTR RNA is actually exists in human tissues, such as fetal liver and heart, pregnant uterus, senescent fibroblasts etc. Through 1990’s to 2000’s, world scientists found several 3’UTR RNAs that functioned as artificial independent RNAs in cancer cells and resulted in tumor suppression. Interestingly, majority of genes for these RNAs have promoter-like structures in their 3’UTR regions, although the existence of their transcribed products as independent 3’UTR RNAs is still to be confirmed. Our studies indicate that the independent 3’UTR RNA is a novel non-coding RNA species whose function should be the regulation not of the expression of their original mRNA, but of some essential life activities of the cell as a whole.
      PPT Version | PDF Version
    • Ishfaq A Bukhari
      Protective Effect of Diltiazem and Fenofibrate Against Ischemia-reperfusion Induced Cardiac Arrhythmias in the Isolated Rat Heart.
      PPT Version | PDF Version
    • A Martin Gerdes
      Wrong about β-blockers! Wrong about positive inotropes! Wrong about Thyroid Hormone treatment of Heart Failure?
      PDF Version
    • Fatih Yalcin
      EARLY IMAGING BIOMARKER IN REMODELING DUE TO HEART FAILURE
      PDF Version
    • Antonio Ferrari
      Spontaneous Ventricular Arrhythmias in Early Clinical Trials A Report from a Single and Repeated Ascending Dose Study
      PDF Version
    • Samuel C Dudley
      Novel biomarkers for diastolic heart failure
      PDF Version
    • Abdulaziz U Joury
      Acute Myocardial Infarction as First Presentation among patients with Coronary Heart Disease
      PPT Version | PDF Version
    • Mohamed Chahine
      A novel mechanism of an SCN5A mutation causing mixed arrhythmias associated with dilated cardiomyopathy
      PDF Version
    • Helena Dominguez
      Can we protect the brain against thromboembolism during open heart surgery? LAACS project
      PDF Version
    • Saverio Gentile
      Ion channels phosphorylopathy: 3rd International Conference on Clinical & Experimental Cardiology April 15-17, 2013 A link between genomic variations and heart arrhythmia
      PDF Version

    Recommended Conferences

    • 23rd International Conference on Heart Diseases & Angiology
      Oct 16-17, 2017 Budapest, Hungary
    • 20th European Cardiology Congress
      October 16-18, 2017 Budapest, Hungary
    • 3rd Global Summit on Heart Diseases
      November 02-04, 2017 Bangkok, Thailand
    • 22nd World Cardiology Congress
      December 11-12, 2017 Rome, Italy

    Relevant Topics

    Peer Reviewed Journals
     
    Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
    International Conferences 2017-18
     
    Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

    Contact Us

    Agri, Food, Aqua and Veterinary Science Journals

    Dr. Krish

    [email protected]

    1-702-714-7001 Extn: 9040

    Clinical and Biochemistry Journals

    Datta A

    [email protected]

    1-702-714-7001Extn: 9037

    Business & Management Journals

    Ronald

    [email protected]

    1-702-714-7001Extn: 9042

    Chemical Engineering and Chemistry Journals

    Gabriel Shaw

    [email protected]

    1-702-714-7001 Extn: 9040

    Earth & Environmental Sciences

    Katie Wilson

    [email protected]

    1-702-714-7001Extn: 9042

    Engineering Journals

    James Franklin

    [email protected]

    1-702-714-7001Extn: 9042

    General Science and Health care Journals

    Andrea Jason

    [email protected]

    1-702-714-7001Extn: 9043

    Genetics and Molecular Biology Journals

    Anna Melissa

    [email protected]

    1-702-714-7001 Extn: 9006

    Immunology & Microbiology Journals

    David Gorantl

    [email protected]

    1-702-714-7001Extn: 9014

    Informatics Journals

    Stephanie Skinner

    [email protected]

    1-702-714-7001Extn: 9039

    Material Sciences Journals

    Rachle Green

    [email protected]

    1-702-714-7001Extn: 9039

    Mathematics and Physics Journals

    Jim Willison

    [email protected]

    1-702-714-7001 Extn: 9042

    Medical Journals

    Nimmi Anna

    [email protected]

    1-702-714-7001 Extn: 9038

    Neuroscience & Psychology Journals

    Nathan T

    [email protected]

    1-702-714-7001Extn: 9041

    Pharmaceutical Sciences Journals

    John Behannon

    [email protected]

    1-702-714-7001Extn: 9007

    Social & Political Science Journals

    Steve Harry

    [email protected]

    1-702-714-7001 Extn: 9042

     
    © 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
    adwords